DePuy Pinnacle Hip Class Action Goes to Trial in London

Trial began in London this week for a class action lawsuit involving hundreds of claims for individuals who have experienced problems with a DePuy Pinnacle hip replacement, raising allegations similar to those presented in thousands of U.S. lawsuits over the metal-on-metal implant.

According to a report published by the Telegraph, the hip class action is believed to be the largest of its kind in the U.K.’s history.

Trial began on Monday, involving claims that DePuy, and its parent company Johnson & Johnson, sold defective and unreasonably dangerous hip replacement systems, which may shed metallic debris into the body, causing catastrophic failure of the implant and the need for risky revision surgery.

"*" indicates required fields

"*" indicates required fields

The case involves about 300 individuals, but there are hundreds more on standby, awaiting outcome of the trial, which is projected to last through late January 2018.

In the United States, more than 9,000 hip replacement lawsuits are pending over the DePuy Pinnacle implant, and several early trial dates have resulted in massive damage awards agains the manufacturer.

In December 2016, Johnson & Johnson and its DePuy Orthopaedics subsidiary were hit with a staggering $1 billion verdict in a bellwether trial involving six plaintiffs. While the damages were later reduced to about $500 million, the verdict came after another jury award of $500 million for five plaintiffs in March 2016, which was later reduced to $151 million under Texas state damage caps.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Ocaliva, promoted as a treatment to prevent liver injury, has been recalled following reports of high rates of liver damage and patient deaths.
Women are sharing alarming reports of pain, infections, and reconstruction failures caused by internal bra mesh implants like GalaFLEX, as the FDA confirms these devices were never approved for breast surgery and lawsuits now allege manufacturers failed to warn about the risks.